Key Trends in Offshoring Pharmaceutical R&D: Company strategies, emerging markets and impact on ROI

‘Key Trends in Offshoring Pharmaceutical R&D' is a report published by Business Insights that evaluates the offshore R&D strategies that can reduce development times and improve productivity, with analysis of a variety of strategic partnerships, academic collaborations, and outsourcing opportunities.

This report identifies emerging areas of technological and scientific significance across the globe and examines the offshore strategies and investments of the top 20 pharma and biotech companies across Asia, Australia, Central and Eastern Europe, Latin America and the Far East. This report also provides a financial and managerial valuation of leading companies based on their P/E ratio, return on assets (ROA) and return on investment (ROI) and measures company performance against the healthcare industry, pharmaceutical and biotechnology sectors and leading shares of the S&P500.

• Authorized Generic Pharmaceuticals (29/06/2010)
• Melanoma (23/06/2010)
• Drug Repositioning & R&D Enhancement (07/06/2010)

• Gastric Cancer (15/06/2009)
• Global Industry Almanac (05/06/2009)
• Schizophrenia (29/05/2009)
• CNS Market Overview (29/05/2009)
• Pricing and Reimbursement in the UAE (08/05/2009)
• Future Pharmaceutical Industry Trends (17/04/2009)
• Generic Benchmarking (17/04/2009)
• Tuberculosis (07/04/2009)
• Healthcare Technology Opportunities (30/03/2009)

---